EXcorLAB GmbH

Company

    • Company type:
      • Research & Development
      • Service Provider
    • Year founded:
    • 2005
    • Employees (at the site):
    • 14
    • Turnover range:
    • <5m EUR
    • Products/services:
    • Clinical trials of medical devices with/without CE-label. Sheep model of hemodialysis and apheresis. Blood/material interaction (biocompatibility according to ISO 10993-4) with fresh human blood in vitro. Hemodialysers (EN 8637), apheresis columns and systems, oxygenators. Complement activation, activation of neutrophils, activation of coagulation and of platelets, analysis of protein adsorption. Transport of compounds through membranes. Correlation between biocompatibility and physicochemical surface analysis, polymers, metals, ceramics in contact with blood and cells, analysis of surface coatings and modifications, membranes, membrane transport characteristics of biological molecules, diffusion, convection, cytotoxicity, pyrogenicity, LAL or cytokine assay.

    • Core competencies:
    • CRO in nephrology, for hemodialysis and apheresis. Biochemical testing and calibration laboratory certified according to EN ISO/IEC 17025:2005

    • Language skills:
    • English
      French
      German
    • Key Tech / section:
      • Biotechnology: Contract research (CROs) and contract manufacturing (CMOs)
      • Biotechnology: Tissue engineering and regenerative medicine
      • Medical Technology: Dialysis, apheresis
      • Medical Technology: Implants, biomaterials, tissue engineering
    • Industries NACE:
      • 72: Scientific research and development
    • Certification:
    • Akkreditiert nach DIN EN ISO/IEC 17025:2005

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
      • Germany
      • Japan
      • United States
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Christoph Sauvant (Mr.)
      - Management